Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Medicover picks up 22 per cent stake in MaxCure Hospitals

      Medicover picks up 22 per cent stake in MaxCure Hospitals

      Ruby Khatun Khatun23 Aug 2017 11:30 AM IST
      Hyderabad: Hyderabad-based MaxCure Group of Hospitals said European healthcare provider Medicover may pick up 51 per cent stake in it for a total of...
      Massive California verdict expands Johnson and Johnsons talc battlefield

      Massive California verdict expands Johnson and Johnsons talc battlefield

      Ruby Khatun Khatun23 Aug 2017 11:00 AM IST
      NEW YORK: A massive California verdict in a lawsuit alleging Johnson and Johnson's talc-based products cause cancer has opened a new front in the...
      Aurobindo Pharma gets USFDA nod for anti-HIV drug

      Aurobindo Pharma gets USFDA nod for anti-HIV drug

      Ruby Khatun Khatun23 Aug 2017 10:30 AM IST
      New Delhi: Aurobindo Pharma has received tentative approval from the USFDA for dolutegravir, lamivudine and tenofovir disoproxil fumarate tablets,...
      Pfizer gets patent for pneumonia vaccine in India

      Pfizer gets patent for pneumonia vaccine in India

      Ruby Khatun Khatun23 Aug 2017 10:00 AM IST
      New Delhi: Multinational drug major Pfizer Inc said it has been granted patent in India for its vaccine Prevenar 13, used for protection against...
      Lupin gets EIR from USFDA for Aurangabad unit

      Lupin gets EIR from USFDA for Aurangabad unit

      Ruby Khatun Khatun23 Aug 2017 10:00 AM IST
      New Delhi: Drug firm Lupin said it has received establishment inspection report (EIR) from the US health regulator for its Aurangabad plant in...
      AstraZeneca ups investment in messenger RNA drugs with Ethris deal

      AstraZeneca ups investment in messenger RNA drugs with Ethris deal

      Ruby Khatun Khatun23 Aug 2017 9:30 AM IST
      FRANKFURT: AstraZeneca has stepped up its investment in messenger RNA drugs, a promising approach in genetic therapy, by spending more than 25 million...
      Johnson and Johnson ordered to pay 417 million dollar in trial over talc cancer risks

      Johnson and Johnson ordered to pay 417 million dollar in trial over talc cancer risks

      Ruby Khatun Khatun22 Aug 2017 1:28 PM IST
      A California jury on Monday ordered Johnson and Johnson to pay $417 million to a woman who claimed she developed ovarian cancer after using the...
      ICMR partners with IVI, invests Rs 3.20 crore for vaccine development in India

      ICMR partners with IVI, invests Rs 3.20 crore for vaccine development in India

      Ruby Khatun Khatun22 Aug 2017 11:30 AM IST
      New Delhi: The Indian Council of Medical Research (ICMR) and the Union Ministry of Health inked a pact with the International Vaccine Institute (IVI),...
      Suven Life secures product patent in Japan

      Suven Life secures product patent in Japan

      Ruby Khatun Khatun22 Aug 2017 10:30 AM IST
      New Delhi: Suven Life Sciences on Monday said it has secured a product patent in Japan to be used for developing therapeutic agents that are useful in...
      Cipla launches Nicotex Nicotine patches

      Cipla launches Nicotex Nicotine patches

      Ruby Khatun Khatun22 Aug 2017 10:00 AM IST
      MUMBAI: Cipla Health, an arm Cipla with a focus on consumer healthcare products, launched Nicotex Nicotine patches to help a smoker kick the habit in...
      Jubilant gets USFDA nod for Drax Exametazime

      Jubilant gets USFDA nod for Drax Exametazime

      Ruby Khatun Khatun22 Aug 2017 9:45 AM IST
      New Delhi: Drug firm Jubilant Life Sciences on Monday said it has received new drug application approval from the US health regulator for Drax...
      New Novartis drug takes aim at tough-to-treat malaria

      New Novartis drug takes aim at tough-to-treat malaria

      Ruby Khatun Khatun22 Aug 2017 9:30 AM IST
      LONDON: Novartis is taking aim at drug-resistant malaria - a growing global problem- by launching clinical trials of the first new antimalarial...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok